AC Immune
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $25,485 | $687 | $687 | $14,801 |
Gross Profit | 25,485 | -16,451 | 157 | |
EBITDA | 6,065 | -22,178 | -4,162 | |
EBIT | 5,536 | -22,726 | -4,717 | |
Net Income | 5,503 | -22,760 | -22,760 | -4,744 |
Net Change In Cash | 25,485 | 687 | 687 | 14,801 |
Free Cash Flow | -14,312 | 72,959 | 72,959 | -16,357 |
Cash | 32,417 | 51,564 | 51,564 | 78,494 |
Basic Shares | 100,858 | 99,680 | 99,549 | 86,741 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $14,801 | $3,935 | $944 | $15,431 |
Gross Profit | -39,805 | -56,401 | -62,282 | -44,056 |
EBITDA | -51,832 | -69,054 | -77,113 | -61,260 |
EBIT | -54,047 | -71,413 | -79,010 | -63,227 |
Net Income | -54,233 | -70,753 | -72,996 | -62,105 |
Net Change In Cash | 14,801 | 3,935 | 944 | 15,431 |
Free Cash Flow | -61,209 | -74,807 | -68,324 | -61,223 |
Cash | 78,494 | 31,586 | 82,216 | 160,893 |
Basic Shares | 84,694 | 83,554 | 74,951 | 71,900 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | $0.06 |
2024-06-30 | -$0.23 |
2024-03-31 | -$0.18 |
2023-12-31 | -$0.05 |
